US Patent Issued to The General Hospital on Feb. 25 for "GHRH or analogues thereof for use in treatment of hepatic disease" (Massachusetts Inventor)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,233,107, issued on Feb. 25, was assigned to The General Hospital Corp. (Boston).

"GHRH or analogues thereof for use in treatment of hepatic disease" was invented by Steven K. Grinspoon (Weston, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to novel methods for preventing, slowing the progression of, or treating nonalcoholic fatty liver (NAFL), nonalcoholic steatohepatitis (NASH), and/or liver fibrosis, and/or reducing the risks of liver cancer in subjects, such as HIV-infected subjects, using a GHRH molecule, e.g., trans-3-hexenoyl-GHRH(1-44)-NH2, or a pharmaceutically acceptable salt thereof. The subjects may have...